Isomorphic Labs
Jeffrey St-Denis is a Senior Research Investigator at Isomorphic Labs since December 2023, previously serving as Principal Scientist at Dunad Therapeutics from June 2022 to December 2023. Prior experience includes roles as Senior Research Associate and Research Associate in Medicinal Chemistry at Astex Pharmaceuticals (UK) between March 2020 and March 2020, and January 2015 to March 2020, respectively. Jeffrey St-Denis earned a Doctor of Philosophy in Organic Chemistry from the University of Toronto, following a Master of Science in Organic Chemistry from McGill University, and a Bachelor of Science in Biology from Niagara University.
Isomorphic Labs
7 followers
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.